At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 21, 2008 bloch stephen m Director Automatic Sell 2,436 8.50
Sep 3, 2008 crowley john f Officer Automatic Sell 2,500 13.75 - 13.79
Sep 4, 2008 crowley john f Officer Automatic Sell 2,500 13.83 - 13.85
Sep 5, 2008 crowley john f Officer Automatic Sell 2,500 13.74 - 13.74
Oct 2, 2007 dentzer james e Officer Disposition (Non Open Market) 2,500 17.35
Aug 28, 2008 palling david Officer Automatic Sell 2,500 13.77
Jul 28, 2008 palling david Officer Automatic Sell 2,500 15.08
Feb 28, 2008 palling david Officer Sell 2,500 10.46 - 10.55
Jun 29, 2009 palling david Officer Automatic Sell 2,500 10.54
Sep 29, 2008 palling david Officer Automatic Sell 2,500 15.03 - 16.22
Oct 21, 2008 patterson matthew r Officer Automatic Sell 2,500 10.51
Sep 2, 2008 crowley john f Officer Automatic Sell 2,600 13.75 - 13.82
Oct 2, 2008 crowley john f Officer Automatic Sell 2,600 15.06 - 15.13
Oct 28, 2008 bloch stephen m Director Automatic Sell 2,601 8.50
Sep 22, 2008 bloch stephen m Director Automatic Sell 2,829 16.02
Oct 27, 2008 bloch stephen m Director Automatic Sell 2,942 8.89
Oct 29, 2008 bloch stephen m Director Automatic Sell 3,000 8.51
Oct 30, 2008 bloch stephen m Director Automatic Sell 3,000 9.54
Oct 23, 2008 bloch stephen m Director Automatic Sell 3,000 9.76
Oct 24, 2008 bloch stephen m Director Automatic Sell 3,000 9.70
Showing 101-120 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy